10 Healthcare Stocks to Buy Today According to Steven Cohen’s Point72 Asset Management
In this piece we will take a look at the 10 healthcare stocks to buy today according to Steven Cohen's Point72 Asset Management.
Posts Tagged ‘NASDAQ:SGEN’
10 Best Healthcare Stocks To Buy In 2022
In this article, we discuss 10 best healthcare stocks to buy in 2022.
Did Hedge Funds Get Seagen Inc. (SGEN) Right?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Top 10 Stock Picks of Paul Marshall and Ian Wace’s Marshall Wace LLP
In this article, we discuss the top 10 stock picks of Paul Marshall and Ian Wace's Marshall Wace LLP.
10 Healthcare Stocks to Buy Now According to Billionaire Louis Bacon
In this article, we discuss the 10 healthcare stocks to buy now according to billionaire Louis Bacon.
5 Pharmaceutical Stocks to Buy Based on Billionaire Ken Griffin’s Portfolio
In this article, we discuss the top 5 pharmaceutical stocks to buy based on billionaire Ken Griffin’s portfolio.
Hedge Funds Are Piling Into Seagen Inc. (SGEN)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
10 Best Healthcare Stocks to Buy According to Greg Martinez’s Parkman Healthcare Partners
In this article, we discuss the 10 best healthcare stocks to buy according to Greg Martinez's Parkman Healthcare Partners.
5 Biotech and Pharma Stocks to Buy According to Billionaire Steve Cohen
In this piece, we will take a look at the 5 biotech and pharma stocks to buy according to billionaire Steve Cohen. If you want to check out more stocks and learn about Mr.
Is Seagen Inc. (SGEN) A Good Stock To Buy?
With the second-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Hedge Fund and Insider Trading News: Bill Miller, Michael Burry, Tribeca Investment Partners, NGL Energy Partners LP (NGL), Seagen Inc (SGEN), and More
One hedge fund in Asia is betting big on the growing interest in carbon offsets to protect forests, as industries and policy makers start to make efforts to cut emissions.
Hedge Funds Have Never Been This Bullish On Seagen Inc. (SGEN)
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is SGEN Stock A Buy or Sell?
In this article we will check out the progression of hedge fund sentiment towards Seagen Inc. (NASDAQ:SGEN) and determine whether it is a good investment right now.
Carillon Tower Remains Optimistic in Seagen (SGEN) Despite its Poor Performance
Carillon Tower Advisers, an investment management firm, published its fourth quarter 2020 “Carillon Eagle Mid Cap Growth Fund” investor letter – a copy of which can be downloaded...
5 Fastest Growing Biotech Companies in the US
In this article we discuss the 5 Fastest Growing Biotech Companies in the US.
Were Hedge Funds Right About Warming Up To Seagen Inc. (SGEN)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 823 active prominent money ...
Hedge Funds Never Been This Bullish On Seattle Genetics, Inc. (SGEN)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Seattle Genetics, Inc. (SGEN) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Fund and Insider Trading News: Steve Cohen, Anthony Scaramucci, Angelo, Gordon & Co., Conagra Brands Inc (CAG), McCormick & Company, Incorporated (MKC), and More
The stock markets have been seesawing and many experts are as flummoxed. Here’s what leading investors Warren Buffett, Ray Dalio, and Howard Marks have to say.
Do Hedge Funds Love Seattle Genetics, Inc. (SGEN)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been This Bullish On Seattle Genetics, Inc. (SGEN)
We hate to say this but, we told you so.
How Did Seattle Genetics, Inc. (SGEN) Compare Against Top Hedge Fund Stocks in 2019?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Hedge Funds Had Impeccable Timing Buying Seattle Genetics, Inc. (SGEN)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Fund and Insider Trading News: Jim Simons, Nelson Peltz, Baker Bros. Advisors, Facebook Inc (FB), Covenant Transportation Group, Inc. (CVTI), and More
Anyone looking to learn how a quant fund conquered the financial world should go out and buy Greg Zuckerman’s “The Man Who Solved the Market” when it’s released next week...
Did Hedge Funds Drop The Ball On Seattle Genetics, Inc. (SGEN) ?
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in...
Here’s What Hedge Funds Think About Seattle Genetics, Inc. (SGEN)
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Were Hedge Funds Right About Buying Seattle Genetics, Inc. (SGEN)?
"October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers being '08 and the Crash of '87...
Hedge Funds Are Dumping Seattle Genetics, Inc. (SGEN)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Hedge Fund and Insider Trading News: Dan Loeb, Michael Platt, Rapid7 Inc (RPD), Seattle Genetics, Inc. (SGEN), PHI Group, Inc. (PHIL), and More
The stock market’s main gauges will rack up weekly gains of 2% or more, if they can just make it through today’s session unscathed.
Hedge Fund and Insider Trading News: David Einhorn, Alan Howard, Philippe Laffont, Nymox Pharmaceutical Co. (NYMX), ALJ Regional Holdings, Inc. (ALJJ), and More
Hedge fund manager David Einhorn said a shift in favor of value stocks may soon be coming even after his firm posted its worst underperformance in almost two decades.
13D Filing: Baker Bros. Advisors and Seattle Genetics Inc (SGEN)
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
13D Filing: Baker Bros. Advisors and Seattle Genetics Inc (SGEN)
You can access the original SEC filing by clicking here.
Hedge Funds Are Coming Back to Seattle Genetics, Inc. (SGEN)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that...
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California.
Seattle Genetics Inc (SGEN): Baker Bros. Advisors Raises Stake
Julian and Felix Baker's Baker Bros.
Delving Into Seattle Genetics, Inc. (SGEN)’s Upcoming Readout
Seattle Genetics, Inc. (NASDAQ:SGEN) just reported second quarter financials, and the company is up nearly 10% on the data.
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros...
Seattle Genetics Inc (SGEN): Baker Bros. Keeps Buying Shares
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors.
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.
13D Filing: Baker Bros. Advisors Buys More Shares of Seattle Genetics Inc (SGEN)
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker's Baker Bros.
Billionaire Christian Leone Boosts Stake in This TV Station Operator, Nelson Peltz Lifts Stake in Struggling Pentair plc. (PNR), Plus 2 Other Moves
Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should have avoided to invest in...
The Smart Money Is Hoarding Shares of These 10 Healthcare Stocks: Part 1
Given elite hedge funds have filed their latest 13F's, we have an opportunity to analyze what hedge funds like and what they don't like.
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today.
Here is What Hedge Funds Think About Seattle Genetics, Inc. (SGEN)
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman.
Strong Insider Selling Activity Detected: Cheniere Energy Inc. (LNG) and Others
Generally, insider trading activity represents an important tool in the process of fundamental security analysis, as it can offer some insights on how insiders feel about the ...
Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another
Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN).
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker's Baker Bros. Advisors is making a habit of hitting home runs in 2015.
Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks
Julian Baker and Felix Baker's Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015.
